Literature DB >> 9382668

A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us?

G S Boyer1, D W Templin, A Bowler, R C Lawrence, D F Everett, S P Heyse, J Cornoni-Huntley, W P Goring.   

Abstract

BACKGROUND: Undiagnosed cases of seronegative spondyloarthropathy (Spa) are often observed during epidemiologic studies.
OBJECTIVE: To determine the extent of and the reasons for the underdiagnosis of Spa.
METHODS: We studied 2 groups of Alaskan native patients with Spa using a standardized protocol that included an interview, physical examination, medical record review, and radiographic and laboratory examinations. One group consisted of patients identified in a communitywide epidemiologic study; the other group consisted of patients from related but geographically separate populations who had been diagnosed by a specialist in the hospital or a specialty clinic. All cases met the current classification criteria for Spa. The clinical and demographic features of the cases in the 2 groups were compared.
RESULTS: Fifty-five (72%) of the 76 community cases that we identified in the epidemiologic study had not been diagnosed previously as Spa. Among the undiagnosed patients were 34 (94%) of the 36 women, 11 (65%) of the 17 patients with ankylosing spondylitis, 12 (36%) of the 33 patients with reactive arthritis, and 24 (100%) of those with undifferentiated Spa. The community and specialty clinic patient groups were similar in age of onset of joint and back pain and in overall symptoms. The specialty clinic group had a higher proportion of men, more severe disease, and a higher frequency of iritis.
CONCLUSIONS: The diagnosis of Spa was missed more often than not in the primary care setting, probably because most of the cases were of mild or moderate severity and did not fit the classic descriptions of spondyloarthropathic disorders. The higher proportion of men among the specialty clinic cases probably reflects provider expectation as well as a slightly milder disease course in women.

Entities:  

Mesh:

Year:  1997        PMID: 9382668

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

Review 1.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Authors:  Nuran Turkcapar; Murat Toruner; Irfan Soykan; Olcay Tiryaki Aydintug; Hulya Cetinkaya; Nursen Duzgun; Ali Ozden; Murat Duman
Journal:  Rheumatol Int       Date:  2005-09-01       Impact factor: 2.631

3.  Screening and referral for axial spondyloarthritis--need of the hour.

Authors:  Abhijeet Danve; Atul Deodhar
Journal:  Clin Rheumatol       Date:  2015-05-07       Impact factor: 2.980

Review 4.  Diagnosis and classification in spondyloarthritis: identifying a chameleon.

Authors:  Astrid van Tubergen; Ulrich Weber
Journal:  Nat Rev Rheumatol       Date:  2012-03-27       Impact factor: 20.543

Review 5.  Golimumab for the treatment of ankylosing spondylitis: a NICE single technology appraisal.

Authors:  Nigel Armstrong; Manuela Joore; Thea van Asselt; Kate Misso; Nathan Manning; Florian Tomini; Jos Kleijnen; Rob Riemsma
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

6.  Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria.

Authors:  Umit Dincer; Engin Cakar; M Zeki Kiralp; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

7.  Ankylosing spondylitis: recent breakthroughs in diagnosis and treatment.

Authors:  Saeed A Shaikh
Journal:  J Can Chiropr Assoc       Date:  2007-12

8.  The co-morbidity burden of children and young adults with autism spectrum disorders.

Authors:  Isaac S Kohane; Andrew McMurry; Griffin Weber; Douglas MacFadden; Leonard Rappaport; Louis Kunkel; Jonathan Bickel; Nich Wattanasin; Sarah Spence; Shawn Murphy; Susanne Churchill
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

Review 9.  Systematic review of rheumatic disease phenotypes and outcomes in the Indigenous populations of Canada, the USA, Australia and New Zealand.

Authors:  Kelle Hurd; Cheryl Barnabe
Journal:  Rheumatol Int       Date:  2016-12-17       Impact factor: 2.631

10.  Ankylosing spondylitis in iran; late diagnosis and its causes.

Authors:  Mehrzad Hajialilo; Amir Ghorbanihaghjo; Alireza Khabbazi; Suosan Kolahi; Nadereh Rashtchizadeh
Journal:  Iran Red Crescent Med J       Date:  2014-04-05       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.